Bend Research signs technology licensing agreement with Merck
Merck gains access to spray dried dispersion technology
Bend Research, a US drug-formulation development and manufacturing firm, has signed a licensing agreement with Merck, through a subsidiary.
Under the terms of the agreement, Bend Research will provide Merck with access to its proprietary spray dried dispersion (SDD) technology.
The Bend, Oregon-based firm may also give Merck access to other drug-delivery platforms and intellectual property, including modified-release technologies and drug-discovery formulation tools.
Under the agreement, the two firms will use their scientific and engineering capabilities to solve complex formulation and process-development problems with a view to transferring these solutions to a cGMP environment.
